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Abstract
Obesity is a worldwide disease associated with multiple severe adverse consequences and comorbid conditions. While 
an increased body weight is the defining feature in obesity, etiologies, clinical phenotypes and treatment responses vary 
between patients. These variations can be observed within individual treatment options which comprise lifestyle interven-
tions, pharmacological treatment, and bariatric surgery. Bariatric surgery can be regarded as the most effective treatment 
method. However, long-term weight regain is comparably frequent even for this treatment and its application is not without 
risk. A prognostic tool that would help predict the effectivity of the individual treatment methods in the long term would be 
essential in a personalized medicine approach. In line with this objective, an increasing number of studies have combined 
neuroimaging and computational modeling to predict treatment outcome in obesity. In our review, we begin by outlining 
the central nervous mechanisms measured with neuroimaging in these studies. The mechanisms are primarily related to 
reward-processing and include “incentive salience” and psychobehavioral control. We then present the diverse neuroimaging 
methods and computational prediction techniques applied. The studies included in this review provide consistent support for 
the importance of incentive salience and psychobehavioral control for treatment outcome in obesity. Nevertheless, further 
studies comprising larger sample sizes and rigorous validation processes are necessary to answer the question of whether or 
not the approach is sufficiently accurate for clinical real-world application.
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ALFF  Amplitude of low frequency fluctuations
BMI  Body mass index
BS  Bariatric surgery
CR  Cue reactivity
CrvR  Craving regulation
CSF  Cerebrospinal fluid
D2R  Dopamine receptor subtype D2
DA  Dopamine
DD  Delay discounting
dlPFC  Dorsolateral prefrontal cortex
DTI  Diffusion tensor imaging
FC  Functional connectivity
FCD  Functional connectivity density
fMRI  Functional magnetic resonance imaging
GM  Grey matter
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IC  Independent component
LAGB  Laparoscopic adjustable gastric banding
LI  Lifestyle intervention
LMM  Linear mixed model
LOO-CV  Leave-one-out cross validation
MRI  Magnetic resonance imaging
OLS  Ordinary least squares
PE  Physical exercise
PET  Positron-Emission-Tomography
PI  Pharmacological intervention
RS  Resting-state
RYGB  Roux-en-Y gastric bypass
SG  Sleeve gastrectomy
sMRI  Structural magnetic resonance imaging
SVC  Support vector classification
VBM  Voxel-based morphometry
vmPFC  Ventromedial prefrontal cortex
WM  White matter
1 Introduction
The global obesity epidemic is one of today’s major public 
health concerns. According to the World Health Organiza-
tion, 650 million adults or 13% of the world’s adult popula-
tion were obese in 2016 and the worldwide prevalence in 
adults nearly tripled between 1975 and 2016. In addition to 
these concerning epidemiological characteristics, obesity is 
associated with multiple adverse consequences, including 
increased risk for cardiovascular disease, diabetes, cancer, 
premature mortality as well as depression and anxiety [1–7]. 
Besides social [8], genetic [9], hormonal [10] and behavioral 
[11–13] factors, central nervous factors promote the devel-
opment and maintenance of obesity. Neural mechanisms that 
(i) underlie impaired food reward [14, 15], (ii) link food cues 
to (anticipated) reward [16, 17] and (iii) underlie reduced 
psychobehavioral control [16, 18, 19] are considered the 
main central nervous contributors to obesity. In developed 
countries these effects are increased by 24-h advertisement 
and availability of low cost, calorie dense, and highly palat-
able food.
Compatible with this multi-factorial etiology, three 
groups of treatments exist: lifestyle interventions (LIs), 
bariatric surgery (BS) and pharmacological interventions 
(PIs). LIs include caloric restriction, physical exercise, eat-
ing behavior modification and dietary counselling. Balanced 
hypocaloric diets induce clinically meaningful weight loss 
[20]. Optimal weight loss and maintenance are achieved 
when caloric restriction and physical exercise are combined 
[21, 22]. However, long-term weight regain is relatively 
common [23].
BS is currently the most effective treatment with regard 
to weight loss, attenuation of comorbidity (e.g., type 2 
diabetes) and mortality prevention [24, 25] and thus the 
treatment of choice for severe obesity [26]. Sleeve gas-
trectomy (stomach volume reduction to 80 to 120 mL) is 
the most frequently recommended BS technique. Never-
theless, there is considerable variability in weight loss. 
Weight regain occurs in 20–30% of patients [27–34]. 
Long-term weight regain has been associated with a rever-
sal of surgery-induced hormonal variations (e.g., in ghre-
lin and GLP-1; [35]), post-bariatric hypoglycemia [36], 
dietary non-adherence [37], and physical inactivity [38]. 
Problematic behavioral patterns are likely further aggra-
vated in psychiatric patients [39]. The safety of BS has 
improved drastically in the last two decades, with periop-
erative mortality rates ranging from 0.03 to 0.2% [40–43]. 
However, complications can still occur and include early 
complications such as bleeding, thromboembolism, bowel 
obstruction and wound infection and as well as late com-
plications such as stricture, reflux disease, cholelithiasis, 
hernia, nutritional and vitamin deficiencies, and dumping 
syndrome [44, 45]. In the long term up to 22% of patients 
require reoperation [46–49]. Due to the differences in effi-
ciency and risk between treatment options, a prognostic 
tool which predicts treatment success and could thus guide 
individual treatment choices in a personalized medicine 
framework is highly desirable.
Only few drugs are used in clinical obesity management, 
including Orlistat, a pancreatic lipase inhibitor, Phenter-
mine/topiramate, a sympathomimetic, appetite suppres-
sant, Lorcaserin, a 5-HT2C receptor activator, Naltrexone/
bupropion, a transmitter reuptake inhibitor and Liraglutide, 
a glucagon-like peptide 1 (GLP-1) analogue. Especially 
GLP1-analoge trials have produced promising results with 
Liraglutide treatment usually resulting in a weight loss of 
4 to 6 kg and Semaglutide treatment demonstrating even 
greater weight loss [50, 51]. Side effects of liraglutide 
include gastrointestinal symptoms, such as nausea, diarrhea, 
constipation, and vomiting [52]. PI weight loss is partly or 
completely reversed after treatment [53]. PIs are only recom-
mended as add-on to LIs [54]. See [54] for a more detailed 
overview on LI, [55] for BS, and [52] for PI.
Currently, a variety of studies exist that use computa-
tional approaches and neuroimaging signals to predict treat-
ment outcome in obesity. In this review, we explain the key 
central nervous mechanisms assessed in these studies, pre-
sent the different neuroimaging and computational predic-
tion techniques, and give a detailed overview of existing 
studies. In the Discussion, we pay special attention to the 
questions of (i) whether the results obtained are sufficient 
to legitimate clinical real-world applications (which is pre-
sumably not yet the case), (ii) what could be done to meet 
this requirement and (iii) how statistical analyses could be 
improved to provide more detailed models for “treatment” 
and “treatment outcome”.
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We included longitudinal LI, BS, and PI studies. We 
required a period of at least one months between treatment 
initiation and the latest follow-up. Compatible with the gen-
eral meaning of “prediction” as a forecast of future events 
and of “prediction” as a statistical process modelling some 
factor based on other factors, we included studies that prog-
nose future treatment outcome using neuroimaging biomark-
ers and studies that predict treatment-induced variations 
in outcome markers based on variations in neuroimaging 
parameters across treatment.
2  Central nervous mechanisms affecting 
body weight
At least partially motivated by the discovery of overlap-
ping psychobehavioral symptoms in persons with obesity 
and substance dependence such as loss of control over 
consumption and craving [16, 56], neuroimaging research 
on central nervous parameters impacting body weight has 
focused on three major reward-related mechanisms: Reward 
system hyposensitivity to food consumption, reward system 
hyperresponsivity to stimuli predicting food consumption, 
and dysfunctional psychobehavioral or goal-directed control 
system respectively.
2.1  Reward system hyposensitivity to food 
consumption
A reduced sensitivity of the brain reward system to food 
consumption (including the actual pleasurable impact of 
consumption) is regarded as a factor that triggers exces-
sive overeating as a method of compensation [14, 15, 57]. 
In accordance with addiction research, a reduced striatal 
dopamine (DA) release after food consumption and reduced 
availability of DA receptor subtype D2 (D2R) are discussed 
as causes for said hyposensitivity.
Specifically, Small et al. found a food-intake induced 
DA release after a 16 h fast that reflected the pleasantness 
of food consumption in normal weight persons [58]. This 
is compatible with findings showing that amphetamine-
induced DA release correlates with the experienced pleas-
antness of amphetamine consumption in healthy subjects 
[59] and a reduced DA release in detoxified cocaine abus-
ers [60]. The pleasurable impact of consumption is fre-
quently referred to as “liking” [17]. Van de Giessen et al. 
found reduced DA release in obese persons in the sense 
that amphetamine induced a significant DA release in lean 
but not obese persons [57]. Based on these findings, it was 
concluded that blunted DA release after consumption is a 
mechanism underlying compensatory overeating in obesity 
(e.g., [57]). Moreover, in agreement with findings made for 
addiction [61], obesity research found that the availability 
of striatal D2R is significantly decreased in obese persons 
[15, 62] and is negatively related to their BMI [15]. Con-
sistently, Johnson & Kenny found a progressive decrease 
in D2R-availability accompanied by a progressive increase 
in compulsion-like overeating in rats randomized into an 
overeating condition compared to control animals [14] and 
Geiger et al. found reduced extracellular dopamine in the 
striatum in a comparable experimental setting [63]. Johnson 
& Kenny concluded that the observed progressive dopamin-
ergic hyposensitivity reflects the transition from normal to 
compulsive overconsumption [14].
However, some findings question the importance of (dopa-
minergic) reward system hyposensitivity as a risk factor for 
weight gain. Hardman et al. found that suppressing DA sig-
nals leads to a reduced food intake in humans [64]. Tellez and 
colleagues showed that down-regulation of DA release due 
to a prolonged high-fat diet reduces caloric intake in rodents 
[65]. Several studies on addiction research depleting/antago-
nizing DA functioning did not find an impact on drug or 
food-liking. Only a reduction in motivational properties (i.e., 
of “drug-wanting”, see Sect. 2.2) was found [66, 67]. Impor-
tantly, Tellez and colleagues also showed that application of 
oleoylethanolamine restores DA release [65]. Oleoylethan-
olamine is a lipid messenger whose synthesis is suppressed 
due to the high-fat diet. Their study provides a mechanism 
that explains reduced DA release as a consequence of a 
prolonged high-fat diet. Consistent with this description of 
reduced DA release as a consequence (and not a cause) of an 
excessive calorie intake and given the experimental design 
applied by Johnson & Kenny [14], one might assume that the 
progressive decrease in D2R-availability observed in their 
study reflects the end-point of rather than the transition to 
compulsive overconsumption. See [68–70] for an overview. 
Finally, the exact role of calorie-intake related DA receptor 
alterations appears unclear due to findings of Dobbs et al. 
showing that D2R downregulation can be associated with a 
D1R hyper-reactivity, suggesting more heterogeneous DA 
adaptations [71].
Therefore, a causative role of a DA-mediated reward sys-
tem hyposensitivity for weight gain remains debatable. Only 
one of the two Positron-Emission-Tomography (PET) stud-
ies directly evaluating a link between DA functioning and 
future weight loss [72, 73] found such a link [72]. Authors 
elaborating on alternative neurotransmitters suggest endor-
phins or endocannabinoids as substrates of drug or food lik-
ing (see e.g., [17] for an overview). An important role of 
endorphins would be consistent with findings of the PET 
study not showing a link for DA [73] but showing negative 
associations between body weight variations and μ-opioid 
receptor availability in amygdala, insula, ventral striatum, 
and putamen. In conclusion, additional research on DA-
based reward hyposensitivity appears necessary given con-
tradictory findings.
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2.2  Reward system hyperresponsivity to stimuli 
predicting food consumption
“Incentive salience” is a motivational mechanism consid-
ered to initiate compulsive food seeking and consumption 
after food cue exposure because these cues were coupled 
to reward (consumption) by Pavlovian conditioning in the 
learning history of an individual. Consequently, food cues 
are predictive of food intake and can acquire similar moti-
vational properties as food reward after repeated couplings 
[74]. Incentive salience relies on a hypersensitivity of the 
DA reward system to these cues [17] and corresponds to 
a strong desire, a strong “I want to consume feeling” on a 
psychological level. This desire has consistently been termed 
as “wanting” [17] or “craving” [56].
Early work relating this cue-dependent motivational 
mechanism to striatal DA was done by Schultz et al. who 
showed in a pivotal animal study that the response of striatal 
DA neurons varies across different stages of food exposure. 
Animals respond to palatable food consumption during early 
stages of exposure, but only to cues predicting consumption 
after repeated exposure [75]. Hamid et al. linked striatal DA 
to cue-sensitivity by showing that it reflects the willingness 
to engage in effortful activities to obtain reward after cue 
exposure in rats [76]. Furthermore, the role of striatal DA for 
food wanting in humans was underlined by van de Giessen 
et al. who found that DA release after amphetamine intake 
in obese persons correlated with food craving on trait level 
[57].
Although incentive salience is primarily a motivational 
phenomenon, it also comprises attentional, affective, learning- 
related, and behavioral facets. Consistently, functional 
magnetic resonance imaging (fMRI) studies using cue reac-
tivity (CR) tasks did not only find striatal hyperresponsivity 
to high-calorie food cues but also a hyperresponsivity in 
anterior cingulate cortex and visual areas, amygdala, orbito-
frontal cortex, and hippocampus [77–80]. CR tasks represent 
the key functional paradigms for studying incentive salience 
which contrast neural signals emerging during perception 
of food cues to those during control conditions (see 3.1.1). 
In this framework, the anterior cingulate cortex / amygdala 
/ visual areas are supposed to modulate the attentional [81] 
/ emotional [82] / sensory salience of food cues (cf. [83]). 
The orbitofrontal cortex might underlie stimulus – outcome 
encoding in Pavlovian conditioning [84]. The hippocampus 
plays an inhibitory role in appetitive Pavlovian condition-
ing [82]. Consistent with the concept of incentive salience, 
a hyperresponsivity in these areas was found to predict 
unfavorable treatment outcome in a variety of reviewed CR 
studies.
However, some studies did not support a link between 
incentive salience and treatment outcome. Specifically, nei-
ther the BS fMRI study of Bach et al. nor the PI fMRI study 
of Ten Kulve et al. found significant associations between 
brain activity evoked by food-cue presentation before the 
treatment and treatment-induced weight loss [85, 86].
2.3  Dysfunctional goal‑directed control system
A dysfunctional psychobehavioral or goal-directed control 
system and reduced modulation of incentive salience by 
this system is considered a further mechanism contributing 
to overeating [19]. This can be understood when viewing 
eating behavior from a decision-making perspective. The 
Pavlovian incentive salience mechanism primarily mediated 
by the striatal DA system can be seen as a decision-making 
mechanism favoring choices that have previously been asso-
ciated with immediate and highly rewarding consequences. 
In line with its subcortical location, this striatal mechanism 
does not consider future consequences [19]. By contrast, 
the goal-directed decision-making system is driving (food) 
choices by comparing different options based on action plans 
encoding their present and future consequences [19, 87]. 
Thus, this system could inhibit the impulse to eat a tasty but 
unhealthy food (e.g., triggered by the striatal DA system) 
because it predicts that the negative consequences of future 
overweight outweigh (i.e., have a higher negative value) the 
positive consequences of immediate reward (i.e., their posi-
tive value) [19].
Hare et al. identified value-based goal-directed decision-
making regions in the brain by having self-reported dieters 
choose between two food items: a constant reference item 
with average taste- and health related properties and another 
that varied in these aspects [88]. Ventromedial prefrontal 
cortex (vmPFC) activity predicted the food choice (i.e., 
its value) independent of the food’s tastiness or healthi-
ness. Activity in the dorsolateral prefrontal cortex (dlPFC) 
reflected self-control (i.e., was higher when subjects chose 
healthy). VmPFC and dlPFC activity correlated only dur-
ing successful self-control trials. The authors concluded that 
the vmPFC computes a value-signal which determines food-
choice and relies on both factors, reward (taste) and control 
(health) only when it reflects control-related dlPFC activity. 
VmPFC activity alone only reflects reward (taste).
Another study employed a delay discounting (DD) para-
digm [87]. In DD tasks, participants have to decide repeat-
edly between rapidly available smaller rewards or larger 
rewards available at a later time (see 3.1.2). A weaker pref-
erence for earlier smaller than for larger delayed rewards 
is considered as a behavioral marker for goal-directed con-
trol. This study highlighted the importance of the interplay 
between fronto-parietal control areas and striatal incentive 
salience areas for goal-directed control. Stronger goal-
directed control depends on stronger lateral-prefrontal rela-
tive to striatal activity. Please see [89] for findings suggest-
ing an inhibitory impact of prefrontal on incentive salience 
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regions including striatal ones (modulated by the specific 
calorie-restriction type applied). A direct link between key 
regions of goal-directed and striatal Pavlovian control is con-
sistent with the finding that DA depleted mice do not at all 
initiate goal-directed behaviors including feeding [90]. In 
addition, animal studies suggest that the insular cortex also 
contributes to goal-directed decision-making as lesions to 
this area impaired the ability of rats to devalue food after 
satiety and to adjust their food choice accordingly [91].
The clinical importance of this factor has been demon-
strated on a behavioral level in DD studies showing reduced 
goal-directed control in obese persons [92, 93]. These stud-
ies controlled for nuisance factors (e.g., age and income). 
Studies not controlling for these variables failed to show 
these effects (e.g., [94, 95]). Neuroimaging studies in obese 
subjects revealed a link between reduced D2R availability 
in the striatum and a reduced resting-state (RS) glucose 
metabolism in regions involved in goal-directed decision-
making such as vmPFC and dlPFC [96]. In [97] we could 
demonstrate the importance of behavioral and neural meas-
ures of goal-directed control and their interplay with striatal 
Pavlovian regions for the dietary success of obese persons 
in a 12-week LI. Higher behavioral goal-directed control 
was coupled to better weight loss. Functional connectivity 
(FC) between vmPFC and dlPFC was positively related to 
behavioral control and weight loss and FC between vmPFC 
and dorsal striatum was negatively linked with future weight 
loss. We evaluated the role of the interplay between Pavlo-
vian and goal-directed neural systems in a LI study by test-
ing whether future dietary weight loss and long-term main-
tenance after treatment across 39 months could be predicted 
based on activity assessed in a food CR paradigm, a food-
specific DD paradigm, and the interaction of these activities 
[18]. This revealed a strong link between future long-term 
weight loss and interactions between visual Pavlovian and 
insular control areas.
3  Neuroimaging techniques and parameters 
used for prediction
Task- and RS-fMRI as well as structural MRI (sMRI) are 
the neuroimaging acquisition techniques predominantly 
employed in the reviewed studies. fMRI provides indirect 
markers of neural activity by measuring vascular responses 
to heightened metabolic demands of active neurons [98] 
while sMRI provides information on various brain tissue 
characteristics. Neuroimaging parameters derived for pre-
diction from fMRI and sMRI can be subdivided in two 
major groups: Parameters characterizing specific, local-
ized processing of individual brain regions (“functional 
segregation”) and those reflecting the interplay or FC of 
activity among different regions respectively (“functional 
integration”). All methods described in this section are illus-
trated in Fig. 1.
3.1  Task‑fMRI
Three task-based fMRI paradigms outlined below are cur-
rently used for treatment outcome prediction in obesity: 
CR, DD, and food craving regulation (CrvR). [97, 99–101] 
used them to derive measures of FC, the rest exclusively 
computed markers of localized activity in individual brain 
coordinates (i.e., voxels).
In these task-fMRI studies, markers of localized activ-
ity (referred to as “Voxel CR, DD, or CrvR activity” in 
the following), are computed in a two-step process. First, 
three-dimensional maps of neural activity reflecting the tar-
geted mechanism in individual voxels are determined for 
each participant and time point. Second, these parameters 
are entered into a predictive group-level analysis utilizing 
methods described in Sect. 4.
Task-related FC markers are also computed in a two-step 
procedure (“Seed-to-voxel CR FC” or “Seed-to-voxel DD 
FC”) in the majority of studies evaluating task-related FC 
[97, 99, 100]. First, a seed coordinate sensitive to the evalu-
ated factor is selected based on prior knowledge and the 
association between its time series (potentially modulated 
by the time course of a condition of interest [99, 100]; see 
[102]) and all other voxels is computed. Second, the voxel-
wise correlation/regression coefficients are entered into a 
group-level analysis.
3.1.1  Cue reactivity
The key experimental design to study incentive salience, 
which is applied in the majority of all reviewed studies 
(see Tables 1 - 3), is the food CR paradigm. Reflecting the 
notion that exposure to food-cues (e.g., pictures, taste, odor, 
or imagined food items) can trigger food-wanting/craving 
and subsequently food-intake [74], CR tasks typically pre-
sent pictures of high-calorie food and control items such as 
pictures of neutral objects or low-calorie foods. Participant-
specific voxel contrast maps reflecting activity related to 
incentive salience are then computed by subtracting activ-
ity during the control condition from activity during pres-
entation of palatable foods to control for non-food related 
activation.
3.1.2  Delay discounting
DD tasks are well established experimental designs for 
the study of goal-directed control in obesity (e.g., [18, 97, 
103–106]) in which participants have to decide multiple 
times between immediately available smaller rewards and 
larger delayed ones. Several methods exist for computing 
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participant-specific voxel contrast maps reflecting goal-
directed control in DD tasks such as contrasting more 
immediate options to more delayed ones [87], or contrast-
ing difficult (similar attractiveness of immediate and delayed 
choices) vs. easy trials (dissimilar attractiveness; e.g., [106]). 
Another method is to first determine a behavioral measure 
of goal-directed control that allows modelling the subject-
specific value of options (rewards) based on their reward 
magnitude and delay and to then compute the voxel-wise 
association between this model function and local activity 
(e.g., [97, 107]).
3.1.3  Food craving regulation
Paradigms requiring their participants to actively regulate 
affective states induced by generic emotional stimuli have 
either been applied without changes in obesity research or 
were slightly varied to study craving regulation induced by 
food stimuli. For example, a study investigating emotion 
regulation during presentation of generic affective stimuli 
found that obese persons have more emotion regulation dif-
ficulties assessed via questionnaires than controls. In addi-
tion, higher vmPFC activity during regulation is associated 
with less regulation difficulties [108]. Food CrvR paradigms 
(used for treatment outcome prediction in [68]) evaluate the 
effect of regulation strategies on food-cue elicited craving. 
Trials typically start by presenting a strategy word (e.g., 
“permit” or “regulate” [69]), which is followed by a high- 
or low-calorie food picture that should either be perceived 
in a permissive fashion (i.e., allowing oneself to perceive 
the potentially induced craving) or during application of 
a regulation strategy. Finally, participants rate their desire 
to consume the depicted food. Contrasting signals emerg-
ing during high-calorie food & permit (high-calorie food & 
regulate) vs. low-calorie food & permit (high-calorie food 
& permit) enables computing voxel activity maps for incen-
tive salience (goal-directed control). Thus, this paradigm 
might be seen as a mixture of an incentive salience and goal-
directed control task.
3.2  Resting‑state fMRI
RS fMRI measures spontaneous low-frequency brain activ-
ity under task-free conditions and has revealed fundamen-
tal aspects of how the brain is organized and works, i.e., 
its intrinsic organization in separate networks (i.e., the RS 
networks [109]) or that RS network activity impacts task-
related activity of RS network [110].
3.2.1  Amplitude of low frequency fluctuations
The Amplitude of low frequency fluctuations (ALFF) 
method is applied in three reviewed BS studies [111–113] 
and characterizes spontaneous low-frequency brain activity 
by estimating the magnitude of these fluctuations in a small 
frequency band (e.g., from 0.01 to 0.08 Hertz [114]) for each 
voxel coordinate. Initially, the average square root of the 
power in this frequency band of a given voxel’s time series 
divided (i.e., standardized) by the average of this parameter 
across all voxels was used as voxel ALFF measure [115]. 
The improved fractional ALFF method uses the square root 
averaged across the full power spectrum for a given voxel 
as a standardization method [116]. It was suggested that fre-
quency sub-bands within 0.01 to 0.08 Hertz reflect spontane-
ous low-frequency activity of different neural tissue types 
and that several diseases other than obesity induce altera-
tions in ALFF (see [117] for an overview).
3.2.2  Functional connectivity density mapping
Functional connectivity density (FCD) mapping (employed 
in one reviewed study [118]), estimates the degree of FC 
for each voxel, and primarily aims to reveal areas of dense 
local FC (so-called “hubs”; [119]). Specifically, “local 
FCD” reflects the number of voxels in a cluster surrounding 
a center voxel having at least a predefined FC. “Global FCD” 
corresponds to the number of voxels having a suprathresh-
old FC with the center voxel irrespective of neighborhood 
minus its local FCD. The clinical relevance of FCD was e.g. 
supported by findings of an altered local FCD in schizophre-
nia [120] and a relation of FCD and severity of subclinical 
depressive symptoms in healthy elderly [121].
Fig. 1  Neuroimaging techniques and parameters utilized in the 
reviewed studies. (a)–(c) illustrate the basic layouts of the three fMRI 
tasks, i.e., CR (a), DD (b), and food CrvR (c). The panels (d)–(i) 
depict the different parameters derived from RS fMRI. In particu-
lar, 1d illustrates the ALFF method, (e) FCD mapping. (f) shows a 
component loading map for a RS-network extracted by independ-
ent component analysis. Moreover, (g) illustrates the seed-to-voxel 
FC approach. (h) shows a correlation (i.e., FC) matrix obtained for 
temporal and deep GM regions for RS fMRI data of a single subject 
and time point. FC depicted is thresholded at r =|0.5|. (Only) temporal 
and deep GM regions were selected to facilitate a better readability of 
the panel. The network depicted in (i) corresponds to the areas / FC 
depicted in the correlation matrix in (h). This network has a global 
efficiency of 0.84. (j) illustrates a PET scan using the  [11C] raclopride 
radio-tracer. Finally, (k)–(m) depict the structural MRI measures. 
Specifically, (k) shows a brain voxel map of the GM (left) and WM 
(right) volume of a participant determined with VBM. (l) illustrates 
an approach to cortical thickness estimation that treats the distance 
between two closest vertices on the opposing WM/GM surface and 
the GM/pial surface as measure of cortical thickness for the corre-
sponding cortex segment. (m) illustrates the fractional anisotropy 
determined with DTI for a single participant and time point on the 
left. In order to illustrate the directional information contained in DTI 
maps (and used for fiber tractography), the direction of the first ten-
sor for a given voxel is depicted with a red–green–blue coding on the 
right. For further details, see text
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3.2.3  Independent component analysis
Independent component analysis is a statistical method that 
identifies RS networks by computing so-called independent 
components (ICs). These are transformations of the multi-
variate voxel input data which are stochastically independent 
(and not only mutually uncorrelated as in principal compo-
nent analysis) and can be understood as characteristic RS 
voxel time series (e.g., [122]). One IC reflects the activity 
time course of one RS network. After the ICs are identi-
fied, they can either be related to treatment outcome directly 
as in [123] or relations between ICs/RS networks of inter-
est and voxel-wise RS fMRI time courses are determined 
using participant-specific voxel-wise regression analysis. 
The resulting correlation/regression coefficients are finally 
handed over for a group analysis [124].
3.2.4  Seed‑to‑voxel functional connectivity
The seed-to-voxel FC for RS fMRI (“Seed-to-voxel RS FC”) 
applied by [125–127] is technically identical to its task-
related counterpart described above.
3.2.5  Functional connectivity between anatomical atlas 
regions
FC for prediction has also been computed based on time 
series averaged across voxels located in anatomical atlas 
regions [111, 128–132]. Using averaged regional time series 
requires less priori knowledge as one can simply compute 
the FC between all atlas regions. Another advantage might 
be the method’s relative robustness to outlier voxels through 
spatial averaging. However, the method does not make full 
use of the spatial resolution fMRI is offering.
3.2.6  Functional connectivity network‑analysis
This (group of) technique(s) aims at characterizing the struc-
ture of connected units interacting in complex social, eco-
nomic, genetic, or neural networks [133]. One major aim is 
to assess the efficiency of network information flow [134]. 
Independent of the domain (e.g., social or biological) these 
techniques have shown that networks with a “small-world” 
structure (i.e., having a dense local and a sparse long-range 
connectivity) are both globally and locally efficient with 
regard to information flow because the average distance 
between any pair of units (here: brain regions) in such a 
network is small [135]. One of the reviewed studies [101] 
utilized a network technique for treatment outcome predic-
tion. Specifically, these authors computed FC using the tech-
nique described in 3.2.5 for individual participants first and 
then determined the global efficiency (see [134]) for each 
participant-specific FC pattern for prediction.
3.3  Neurotransmission assessed 
with Positron‑Emission‑Tomography
Positron-Emission-Tomography (PET) is a technique allow-
ing to measure biochemical and physiological activity across 
biological tissues on a voxel-level by applying radio-tracers 
(e.g.,  [11C] raclopride and  [11C] carfentanil) (employed in 
two reviewed studies [72, 73]). This method can be used 
in a task-related or RS fashion and has been applied exten-
sively in obesity research to measure transmission of DA 
and other neurotransmitters (e.g., [15, 57–60]). Steele et al. 
related Roux-en-Y gastric bypass (RYGB)-induced D2R 
availability changes to weight loss in a 6-week period after 
surgery and report a positive association [72]. Karlsson et al. 
related presurgical μ-opioid receptor and D2R availability to 
post-BS weight [73]. While no associations were found for 
D2R, especially amygdala μ-opioid receptor availability was 
negatively associated to future body weight.
3.4  Structural neuroimaging
3.4.1  Brain tissue volume
One of the most frequently evaluated tissue properties in 
structural neuroimaging in general and in the reviewed struc-
tural studies specifically [136–143] is voxel-wise tissue vol-
ume. Except for Best et al. [138], Voxel-Based Morphometry 
(VBM; [144]) was used in these studies for computation. 
VBM is implemented in SPM12 (Wellcome Trust Centre 
for Neuroimaging, Institute of Neurology, UCL, London UK 
http:// www. fil. ion. ucl. ac. uk/ spm). In VBM, anatomical brain 
images are spatially registered to an anatomical reference 
space and segmented into the three tissue types grey matter 
(GM), white matter (WM), and cerebrospinal fluid (CSF). 
By additionally considering the amount of local deforma-
tion applied during spatial registration, the method produces 
markers of the voxel-wise volume for each of the three tis-
sue types (referred to as “Voxel GM or WM volume” in 
the following). Contrary to VBM, the method used by Best 
et al. [138] computes volumes for larger regions included in 
an anatomical atlas and is implemented in FreeSurfer [145, 
146]. For a method comparison, see Guo et al. [147].
3.4.2  Cortical thickness
Another structural brain property evaluated frequently in 
structural neuroimaging in general and in one reviewed 
studies [148] is cortical thickness (implemented e.g., in 
FreeSurfer [146]). In short, this parameter is computed by 
determining the WM/GM transition surface and the GM/
pial transition surface in a first step and by determining the 
distance between these two surfaces for small spatial units 
(“vertices”) in a second.
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3.4.3  Brain diffusion
Diffusion MRI enables evaluating brain fiber characteristics 
by assessing directions of water molecule diffusion and was 
applied in two of the reviewed studies [99, 139]. Specifi-
cally, utilizing the fact that water can diffuse equally into 
any direction in unstructured spaces such as CSF but only in 
directions predetermined by biological structures and their 
integrity in neural tissues, measurement and modelling of 
water molecule diffusion allows evaluating axon bundle ori-
entation and integrity [149]. A method frequently used for 
this purpose is Diffusion Tensor Imaging (DTI). In DTI, 
water molecule diffusion is measured for a predefined num-
ber of diffusion orientations. Subsequently, participant- and 
time point-specific voxel maps reflecting different diffusion 
properties are determined by fitting an ellipsoid to the three-
dimensional diffusion information. The two most important 
fiber characteristics derived thereof are Fractional Anisot-
ropy, which can be understood as the degree of diffusion 
directedness, and Mean Diffusivity, a measure of overall 
diffusivity. Finally, a method complementing DTI is fiber 
tractography which aims at tracing WM tracts based on 
the directional information provided by diffusion-weighted 
MRI. One of the reviewed studies applied tractography [99]. 
Soares et al. provides an overview on DTI and tractography 
including a list of available software packages [150], Maier-
Hein et al. highlights pitfalls in tractography [151].
4  Computational prediction approaches
This section describes the methods used for assessing treat-
ment outcome on the group level across the reviewed stud-
ies. Except for ordinary least squares (OLS) regression, 
these methods are illustrated in Fig. 2.
4.1  Linear regression
4.1.1  Ordinary least square regression
The technique used for treatment outcome prediction on the 
group level in the majority of reviewed studies is voxel-wise 
OLS regression. This technique is implemented in a vari-
ety of software packages such as SPM, FMRIB Software 
Library (FSL) [152], Analysis of Functional NeuroImages 
(AFNI; http:// afni. nimh. nih. gov/ afni) [153], or BrainVoy-
ager (http:// www. brain voyag er. com/) [154]. OLS regres-
sion identifies an optimal set of regression coefficients by 
minimizing the sum of squared differences between true and 
predicted values for the dependent variable (e.g., weight loss 
obtained in a certain interval or brain activity in a certain 
voxel). Given that multiple voxels are tested, methods cor-
recting for family-wise error (e.g., the Random Field Theory, 
Bonferroni, or the maximum statistic method [155–157]) 
have to be applied to evaluate the significance of individual 
voxels’ tests. A drawback in a longitudinal framework is the 
method’s sensitivity to drop-out, as participants have to be 
excluded completely once a single time point is missing (for 
further points, see e.g. [158, 159]).
4.1.2  Linear mixed model regression
Linear mixed models (LMMs; implemented in Freesurfer 
[160, 161] are a newer regression method [162] that has 
been applied in four reviewed studies [18, 136, 138, 163]. 
LMM regression models the variation in the criterion (e.g., 
weight loss) as a linear combination of fixed and random 
effects. The former correspond to parameters that can be 
defined freely by the researcher (e.g. group membership), 
the latter to parameters for which this is not possible because 
they vary in an endogenous, participant-specific fashion 
(e.g., participants’ signal means or trends). LMM regres-
sion has several properties that makes it a suitable candidate 
for the analysis of longitudinal study designs. First, it can 
model a signal sampled across an arbitrary number of time 
points simultaneously. Second, it can handle designs which 
are unbalanced due to participant drop out [162] and has 
thus has higher statistical power than alternative methods 
(e.g., repeated measures analysis of variance based on OLS 
regression) because participants with partially missing data 
need not to be excluded [161]. It has been shown that even 
the inclusion of participants with only a single data point 
can improve the accuracy of LMM regression [161]. Finally, 
unlike repeated measures analysis of variance, LMM regres-
sion is able to cope flexibly with varying data covariation 
across time.
4.2  Support vector classification
Support vector classification (SVC) is a supervised clas-
sification approach used in the majority of reviewed stud-
ies employing machine learning (i.e., [132, 141]). A third 
study employed a combination of Twin networks and 
k-nearest neighbor clustering [130]. Given the rare use 
of this approach in neuroimaging, we would like to point 
Fig. 2  illustrates computational approaches used for treatment out-
come prediction on the group level. In particular, (a) illustrates the 
LMM regression approach and is taken from [18]. (b) depicts an 
application of support vector classification for a hypothetical classi-
fication task in which a classifier has to learn the differences between 
voxel GM patterns belonging to very successful dieters and less suc-
cessful dieters in the training stage. In the next step, the classification 
boundary estimated from the training data is used to predict the class 
of an unknown test person based on their GM pattern. (b) is derived 
from Weygandt et  al. [172]. Finally, (c) shows a hypothetical struc-
tural equation model (in part derived from [169])
◂
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the reader directly to this study for details. In supervised 
classification, a machine learning algorithm tries to learn 
characteristic properties from (e.g., brain activity) pat-
terns representative of different classes (e.g., successful 
vs. non-successful dieters) in a training stage. In its basic 
form, the SVC algorithm does so by identifying a linear 
class boundary (“classification model”) that separates the 
training patterns of two classes and which optimizes the 
trade-off between the number of non-separable patterns 
and classifier complexity [164]. In the test or model vali-
dation stage, the model is evaluated by computing a clas-
sification accuracy measure for unseen test data. Model 
validation techniques range from leave-one-out cross 
validation (LOO-CV) to out-of-sample validation. One 
important aspect arising from this variety and other factors 
such as a putative sensitivity of supervised classification to 
sample size [165] is the use of resampling techniques for 
inference. These consider the conditions under which the 
empirical classification accuracy is obtained. Parametric 
procedures do not possess this property (e.g., [166, 167]).
4.3  Structural equation modelling
Structural equation modelling [168] is a multivariate 
analysis technique applied in one reviewed study [169] 
evaluating whether/how well the relations among hypoth-
esized constructs fit to relations among (“latent” or unob-
servable) mathematical factors representing these con-
structs extracted from a set of (“manifest” or observable) 
empirical data. In structural equation modelling, relations 
between manifest variables and latent constructs (i.e., 
the “measurement model”) and among latent constructs 
(“latent variable model”) have to be specified first. It is 
possible to specify directed effects in the latent variables 
model and thus to assume causal relations among variables 
(see below). Although structural equation modelling is a 
very flexible and powerful tool, several aspects have to be 
taken into consideration. Structural equation modelling 
cannot be used to test causal relations among constructs. 
Instead, structural equation modelling tests whether asso-
ciations in a specific empirical data set fit to the causal 
assumptions held by the researcher. Poor model fits will 
strongly question the validity of these assumptions. How-
ever, good model fits will increase their plausibility, but 
not prove them, and require replication on independent 
data sets [170]. The sensitivity of structural equation mod-
elling to variations in sample size and to violations of dis-
tributional assumptions remains a limiting factor. Methods 
to deal with these problems have e.g., been presented by 
Kock & Hadaya [171] and Hox et al. [172]. See [172] for 
an overview.
5  Study overview
Here we provide a tabular overview of the reviewed stud-
ies. Table 1 gives an overview on LI-based studies, Table 2 
on BS-based studies and Table 3 on PI-based studies.
6  Discussion
In this study, we review current work on computational 
approaches to predicting treatment response in obesity 
using neuroimaging. We started by outlining key CNS 
mechanisms thought to affect treatment outcome and then 
described the neuroimaging techniques and parameters 
as well as computational approaches used for prediction. 
Lastly, we gave an overview on existing studies.
This overview provided a consistent picture on the role 
of CNS mechanisms for treatment outcome in obesity. For 
example, the importance of dopaminergic reward areas 
was underlined by CR studies showing that cue-evoked 
activity in these areas is negatively related to treatment 
outcome [173–177]. The relevance of goal-directed con-
trol regions comprising frontal and parietal areas as well 
as insula was demonstrated in DD tasks directly designed 
to study goal-directed control [18, 97, 104, 106] and in 
CR tasks by showing that cue-related activity of these 
areas has a positive effect on treatment outcome [86, 169, 
178–180]. Task-derived FC and RS FC studies showed 
that higher FC between fronto-parietal and insular goal-
directed control areas on one hand and incentive salience 
areas on the other is accompanied by better treatment 
outcomes [18, 97, 99, 100, 126]. Obesity-related regions 
involved in incentive salience and goal-directed control 
as identified by task fMRI strongly overlap with obesity-
related regions as identified via RS FC [181]. These results 
were complemented by structural neuroimaging studies 
[99, 137–140, 142, 143] showing that higher GM volume 
of goal directed areas was associated with better treat-
ment outcome and higher GM volume of incentive sali-
ence regions with worse outcome.
Some studies did not support a link between incentive 
salience or goal-directed control and treatment outcome. 
The fMRI studies of Bach et al. and Ten Kulve et al. did 
not show such a link [85, 86]. In addition, associations 
between cortical thickness of the superior frontal gyrus 
and weight loss reported by Liu et al. did not reach a mul-
tiple comparison corrected significance level [148]. Simi-
larly, a couple of behavioral studies (not properly control-
ling for well-known nuisance factors) failed to identify 
reduced goal-directed control in obesity (e.g., [94, 95]). 
Thus, due to these null results and the possibility of a 
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publication bias [182], the large number of consistent 
findings mentioned have to be viewed in a critical light. 
Nevertheless, given that the concepts of incentive salience 
and goal-directed control are derived from basic neurosci-
ence on reward and motivation (e.g., [75, 76]), it can be 
assumed that these two CNS mechanisms play an impor-
tant role for treatment outcome in obesity.
Do the presented findings also allow us to conclude 
that the evaluated neuroimaging predictors yield suitable 
biomarkers for obesity treatment outcome in a real-world 
precision medicine approach? Such a conclusion might be 
premature. An important counter argument is that the major-
ity of studies applied correlational techniques evaluating all 
available data in one step (instead of applying model vali-
dation techniques) to analyze many predictors for one cri-
terion assessed in small to moderately sized samples. This 
approach is sensitive to over- (and under-) fitting [183]. 
If the number of predictors is high (e.g., as in voxel-wise 
analyses) and the number of participants small, a statistical 
model for a criterion can occasionally fit this criterion well 
(poorly) because the predictor is not very reliable or varies 
substantially across different measurements. Thus, although 
such correlational analyses yield valid statistical inference 
on the group level if the analyses adequately controlled for 
multiple comparisons and were not circular [184, 185], their 
results might not be generalizable to unseen data and would 
not yield suitable biomarkers. Consequently, suitable bio-
markers have to have a high retest-reliability.
How reliable are which neuroimaging parameters? What 
can be done to improve data reliability? How can a high 
generalizability of a prognostic model to unseen data be 
ensured? Meta-analyses provide answers to the first question. 
Studies assessing the reliability of task fMRI (typically via 
the intraclass correlation (ICC; [186]) for which a poor reli-
ability was defined as ICC < 0.4, a fair as 0.4 ≤ ICC < 0.59, a 
good one as 0.6 ≤ ICC < 0.75, and an excellent as ICC ≥ 0.75 
[187]) reported an average ICC of 0.5 ([188]; N = 15) or 
0.397 ([189]; N = 56). A meta-analysis assessing retest-
reliabilities for RS FC found an average ICC of 0.29 ([190]; 
N = 25). Consistent with Han et al. [191], retest-reliabilities 
computed for volume- and surface-based structural neuroim-
aging parameters by Elliott et al. showed primarily excellent 
ICCs [189]. Thus, together with the fact that structural neu-
roimaging parameters were significantly related to treatment 
outcome, these findings show that structural neuroimaging 
parameters might provide the most suitable biomarkers.
However, it is unclear to which degree the reliabilities 
reported for task fMRI and RS FC can be generalized. First, 
clinical studies applying specific tasks due to disease-related 
theoretical or empirical reasons were severely underrepresented 
in these meta-analyses. Second, especially for Elliott et al., the 
average retest interval was quite long (four months) given that 
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had reduced retest-reliability [188, 189]. The latter finding is 
consistent with the fact that retest-reliability is affected by a 
biomarker’s noise as well as by noise-independent physiologi-
cal alterations occurring over time [192].
Irrespective of whether or not these meta-analyses pro-
vide extremely accurate estimates of retest-reliability for 
fMRI-derived markers, there is space for improvement. 
Consequently, one might ask what to do to improve reli-
ability? Circumstances enabling an accurate reliability 
estimation are an important prerequisite. Given that retest-
reliability is negatively associated with the duration of the 
retest-interval [192], an unbiased estimate requires a short 
time interval. A cross-sectional estimation procedure with 
zero interval length might be optimal in this regard which 
computes reliability based on several data subsets of a sin-
gle scanning session [193]. Given that fMRI data reflect a 
highly complex process and are sensitive to a broad range of 
confounding factors, improvements should aim at adequately 
reducing factors such as head motion, breathing, heart rate, 
hydration, satiation, neuromodulators including caffeine or 
nicotine (e.g., [183]). Specific improvements for FC com-
prise increasing the number of acquired fMRI scans [189, 
190] and combining RS FC data acquired across extended 
scan sessions with complementary task-fMRI data [189]. 
Additionally, FC computation based on a natural viewing 
tasks yielded fair to excellent reliability in a study of Wang 
et al. and was significantly higher than that derived from 
RS [194].
Another step to optimize neuroimaging-based treatment 
outcome prediction for clinical application would aim at 
maximizing the generalizability of a prognostic model to 
unseen data via application of model validation techniques. 
In this approach, different models (e.g., derived from neural 
networks, support vector classifiers, etc.) would be trained 
on a set of training data. Selection of features yielding a 
high prognostic accuracy could then be performed for each 
model separately using independent evaluation data. The 
prognostic performance is then tested once for each model 
based on independent test data and the best is selected for 
application (e.g., [183]).
Consequently, access to highly reliable biomarkers 
derived from adequately powered studies using model 
validation techniques is an important prerequisite for using 
neuroimaging-derived biomarkers for applied treatment 
outcome prediction in clinical practice – a prerequisite that 
might not be met today. Besides these application-related 
aspects, further improvements could entail a more elaborate 
modelling of “treatment-outcome”. This would take multiple 
neuroimaging, hormonal, and outcome markers (see e.g., 
[18, 163, 179]) into consideration. In this regard, the study 
of Szabo-Reed and colleagues might be pioneering as com-
plex associations between brain activity, caloric restrictions, 
program attendance, physical activity and weight loss were 
modeled within a single structural equation model in this 
work [169]. This approach does not only promise to reveal 
a more fine-grained picture of contributing factors but also 
Table 3  Overview on existing pharmacological intervention studies. For the interpretation of parameters reported in columns “Modelling: Out-
come”, “Predictor”, and “Significant prediction results”, please see Table 1
CR cue reactivity, fMRI functional magnetic resonance imaging, OB obese, OLS ordinary least square regression, OUT outcome marker, OW 
overweight, Pred. meth computational prediction method, WL weight loss
Study Modelling Outcome #Participants (per 
group)
Experimental design Predictor Pred. meth Significant prediction 
results
Task-fMRI
Ten Kulve et al. [86] Prognostic:
Bodyweight




T0 (before  
treatment), T0.3 
(after 10 days of 
treatment), T3 
(after 12 weeks of 
treatment)
















T0 (before  
treatment), T0.3 
(after 10 days of 
treatment), T3 
(after 12 weeks of 
treatment)




WL and higher CR 
activity in right 
insula after  
liraglutide vs. after 
insulin
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to facilitate a comparison of prediction accuracy obtained 
by different biomarker compilations.
In conclusion, the reviewed studies provide consistent 
support for the importance of incentive salience and goal-
directed control as central nervous mechanisms mediating 
treatment outcome in obesity. Despite these findings, larger 
studies using statistical methods optimized with regard to 
real-world outcome prediction are needed to determine 
whether the approach is sufficiently accurate for application 
in a personalized medicine framework.
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